EMEA-002232-PIP02-19-M01

Table of contents

Key facts

Active substance
Bis-choline tetrathiomolybdate
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0261/2021
PIP number
EMEA-002232-PIP02-19-M01
Pharmaceutical form(s)
  • Age-appropriate oral solid dosage form
  • Coated tablet
Condition(s) / indication(s)
Treatment of Wilson Disease
Route(s) of administration
Oral use
Contact for public enquiries
Alexion Europe SAS

E-mail: pip.enquiries.eu@alexion.com
Tel. +33 147103621

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating